Medigus Announces Cash Capital Distribution of $1.6 Million
Medigus Ltd. (Nasdaq: MDGS) announced a cash capital distribution of $1.6 million approved by the Tel Aviv District Court on November 13, 2022. The court's approval is valid for 180 days. Following this, on November 17, Medigus' board resolved to distribute the cash to holders of the Company’s ADSs and eligible warrant holders based on their holdings. An announcement regarding the exact timing and details of this distribution will follow.
- Court approval for cash capital distribution of $1.6 million
- Distribution benefits holders of ADSs and eligible warrant holders
- None.
The Company will provide an update regarding the distribution date
Tel Aviv, Israel, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that on November 13, 2022, the Tel Aviv District Court Economic Department approved the Company’s motion for the approval of a cash capital distribution of up to
The approval by the Israeli court is in effect for 180 days.
Following the approval of the Israeli court, Medigus’ board of directors resolved on November 17, 2022 to make a cash capital distribution of
A separate announcement would be made with the exact timing and details of the cash distribution.
About Medigus
Based in Israel, Medigus Ltd. (Nasdaq: MDGS) is a technology company focused on innovative growth partnerships, mainly in advanced medical solutions, digital commerce and electric vehicle markets. Medigus' affiliations in the medical solutions arena include ownership in Polyrizon Ltd. and ownership in industry 4.0 company, ScoutCam Inc. The Company’s affiliates in digital commerce include Gix Internet Ltd., Jeffs' Brands Ltd. and Eventer Technologies Ltd. In the electric vehicle market, Charging Robotics Ltd. and Revoltz Ltd. are also part of the Company’s portfolio of technology solution providers. To learn more about Medigus’ advanced technologies, please visit http://www.medigus.com/.
Forward-Looking Statements
his press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. Because such statements deal with future events and are based on Medigus’ current expectations, they are subject to various risks and uncertainties, and actual results, performance or achievements could differ materially from those described in or implied by the statements in this press release.
The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed in any filings with the SEC. Except as otherwise required by law, Medigus undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release. Medigus is not responsible for the contents of third-party websites.
Company Contact:
Tali Dinar
Chief Financial Officer
+972-8-6466-880
ir@medigus.com
Investor Relations Contact:
Dave Gentry
RedChip Companies Inc.
1-800-RED-CHIP (733-2447)
Or 407-491-4498
MDGS@redchip.com
FAQ
What is the cash distribution amount approved for Medigus (MDGS)?
When was the cash capital distribution approved for Medigus (MDGS)?
How long is the court's approval for the cash distribution of Medigus (MDGS) valid?
Who will receive the cash distribution from Medigus (MDGS)?
